PBH
Price
$79.98
Change
-$0.20 (-0.25%)
Updated
Jul 3 closing price
Capitalization
3.6B
26 days until earnings call
PRGO
Price
$27.20
Change
-$0.06 (-0.22%)
Updated
Jul 3 closing price
Capitalization
4.35B
32 days until earnings call
Interact to see
Advertisement

PBH vs PRGO

Header iconPBH vs PRGO Comparison
Open Charts PBH vs PRGOBanner chart's image
Prestige Consumer Healthcare
Price$79.98
Change-$0.20 (-0.25%)
Volume$243.05K
Capitalization3.6B
Perrigo
Price$27.20
Change-$0.06 (-0.22%)
Volume$454.25K
Capitalization4.35B
PBH vs PRGO Comparison Chart in %
Loading...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PBH vs. PRGO commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBH is a Hold and PRGO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (PBH: $79.98 vs. PRGO: $27.20)
Brand notoriety: PBH and PRGO are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: PBH: 65% vs. PRGO: 36%
Market capitalization -- PBH: $3.6B vs. PRGO: $4.35B
PBH [@Pharmaceuticals: Other] is valued at $3.6B. PRGO’s [@Pharmaceuticals: Other] market capitalization is $4.35B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PBH’s FA Score shows that 1 FA rating(s) are green whilePRGO’s FA Score has 1 green FA rating(s).

  • PBH’s FA Score: 1 green, 4 red.
  • PRGO’s FA Score: 1 green, 4 red.
According to our system of comparison, PBH is a better buy in the long-term than PRGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PBH’s TA Score shows that 4 TA indicator(s) are bullish while PRGO’s TA Score has 5 bullish TA indicator(s).

  • PBH’s TA Score: 4 bullish, 5 bearish.
  • PRGO’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, PRGO is a better buy in the short-term than PBH.

Price Growth

PBH (@Pharmaceuticals: Other) experienced а -1.44% price change this week, while PRGO (@Pharmaceuticals: Other) price change was +2.37% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Reported Earning Dates

PBH is expected to report earnings on Jul 31, 2025.

PRGO is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRGO($4.35B) has a higher market cap than PBH($3.6B). PRGO has higher P/E ratio than PBH: PRGO (341.25) vs PBH (14.90). PRGO YTD gains are higher at: 8.031 vs. PBH (2.420). PRGO has higher annual earnings (EBITDA): 525M vs. PBH (10.8M). PRGO has more cash in the bank: 751M vs. PBH (63.6M). PBH has less debt than PRGO: PBH (1.21B) vs PRGO (4.07B). PRGO has higher revenues than PBH: PRGO (4.66B) vs PBH (1.13B).
PBHPRGOPBH / PRGO
Capitalization3.6B4.35B83%
EBITDA10.8M525M2%
Gain YTD2.4208.03130%
P/E Ratio14.90341.254%
Revenue1.13B4.66B24%
Total Cash63.6M751M8%
Total Debt1.21B4.07B30%
FUNDAMENTALS RATINGS
PBH vs PRGO: Fundamental Ratings
PBH
PRGO
OUTLOOK RATING
1..100
5359
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
10100
SMR RATING
1..100
6091
PRICE GROWTH RATING
1..100
5954
P/E GROWTH RATING
1..100
382
SEASONALITY SCORE
1..100
5040

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRGO's Valuation (71) in the Pharmaceuticals Other industry is in the same range as PBH (85). This means that PRGO’s stock grew similarly to PBH’s over the last 12 months.

PBH's Profit vs Risk Rating (10) in the Pharmaceuticals Other industry is significantly better than the same rating for PRGO (100). This means that PBH’s stock grew significantly faster than PRGO’s over the last 12 months.

PBH's SMR Rating (60) in the Pharmaceuticals Other industry is in the same range as PRGO (91). This means that PBH’s stock grew similarly to PRGO’s over the last 12 months.

PRGO's Price Growth Rating (54) in the Pharmaceuticals Other industry is in the same range as PBH (59). This means that PRGO’s stock grew similarly to PBH’s over the last 12 months.

PRGO's P/E Growth Rating (2) in the Pharmaceuticals Other industry is somewhat better than the same rating for PBH (38). This means that PRGO’s stock grew somewhat faster than PBH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PBHPRGO
RSI
ODDS (%)
Bullish Trend 3 days ago
64%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
60%
Momentum
ODDS (%)
Bearish Trend 3 days ago
52%
Bullish Trend 3 days ago
65%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
68%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
52%
Bullish Trend 3 days ago
60%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
44%
Bullish Trend 3 days ago
58%
Advances
ODDS (%)
Bullish Trend 26 days ago
59%
Bullish Trend 16 days ago
61%
Declines
ODDS (%)
Bearish Trend 3 days ago
50%
Bearish Trend 3 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
66%
Bearish Trend 3 days ago
75%
Aroon
ODDS (%)
Bearish Trend 3 days ago
39%
Bullish Trend 3 days ago
51%
View a ticker or compare two or three
Interact to see
Advertisement
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GMSMX20.200.18
+0.90%
GuideMark® Small/Mid Cap Core Service
RSEBX70.450.41
+0.59%
American Funds SMALLCAP World R2E
EPLCX22.790.12
+0.53%
NYLI Epoch U.S. Equity Yield Class I
DVLCX23.100.10
+0.43%
BNY Mellon Opportunistic Midcap Value C
HRINX53.940.03
+0.06%
Harbor International Administrative

PRGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRGO has been loosely correlated with ORGO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if PRGO jumps, then ORGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRGO
1D Price
Change %
PRGO100%
-0.22%
ORGO - PRGO
47%
Loosely correlated
+4.94%
MLLNF - PRGO
43%
Loosely correlated
N/A
ANIP - PRGO
41%
Loosely correlated
+0.09%
AMRX - PRGO
37%
Loosely correlated
+0.60%
ALKS - PRGO
33%
Poorly correlated
-0.52%
More